UK-headquartered pharmaceutical firm AstraZeneca has entered into a longevity swap with Deutsche Bank which will cover £2.5bn of its pension scheme liabilities and around 10,000 pensioners.
UK-headquartered pharmaceutical firm AstraZeneca has entered into a longevity swap with Deutsche Bank which will cover £2.5bn of its pension scheme liabilities and around 10,000 pensioners.